ReviewInternational journal of molecular sciences2022

Sodium-Glucose Cotransporter-2 Inhibitors-Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials.

Tomohito Gohda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.